Basics |
ADMA Biologics Inc
ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.
|
IPO Date: |
October 18, 2013 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$4.87B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.15 | 2.79%
|
Avg Daily Range (30 D): |
$0.41 | 2.04%
|
Avg Daily Range (90 D): |
$0.51 | 2.69%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.57M |
Avg Daily Volume (30 D): |
2.85M |
Avg Daily Volume (90 D): |
2.77M |
Trade Size |
Avg Trade Size (Sh.): |
198 |
Avg Trade Size (Sh.) (30 D): |
81 |
Avg Trade Size (Sh.) (90 D): |
80 |
Institutional Trades |
Total Inst.Trades: |
1,639 |
Avg Inst. Trade: |
$3.32M |
Avg Inst. Trade (30 D): |
$4.6M |
Avg Inst. Trade (90 D): |
$4.19M |
Avg Inst. Trade Volume: |
.33M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$5.09M |
Avg Closing Trade (30 D): |
$9.32M |
Avg Closing Trade (90 D): |
$9.23M |
Avg Closing Volume: |
507.89K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$.11
|
$.48
|
$.85
|
Diluted EPS
|
$.11
|
$.46
|
$.81
|
Revenue
|
$ 114.8M
|
$ 117.55M
|
$ 426.45M
|
Gross Profit
|
$ 61.1M
|
$ 63.33M
|
$ 219.55M
|
Net Income / Loss
|
$ 26.9M
|
$ 111.9M
|
$ 197.67M
|
Operating Income / Loss
|
$ 34.88M
|
$ 38.32M
|
$ 138.98M
|
Cost of Revenue
|
$ 53.71M
|
$ 54.22M
|
$ 206.9M
|
Net Cash Flow
|
$ -31.52M
|
$ 16.44M
|
$ 51.8M
|
PE Ratio
|
161.46
|
|
|
|
|
|